nafamostat has been researched along with Polyarthritis in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of FUT-175 on the development of adjuvant arthritis in rats were studied and compared with those of indomethacin." | 3.67 | Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation. ( Ino, Y; Iwaki, M; Koshiyama, Y; Oda, M; Sato, T; Suzuki, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ino, Y | 1 |
| Sato, T | 1 |
| Koshiyama, Y | 1 |
| Suzuki, K | 1 |
| Oda, M | 1 |
| Iwaki, M | 1 |
1 other study available for nafamostat and Polyarthritis
| Article | Year |
|---|---|
Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation.
Topics: Animals; Arthritis; Arthritis, Experimental; Benzamidines; Complement Pathway, Classical; Female; Gu | 1987 |